MULTIPLE MYELOMA IN RELAPSE
Clinical trials for MULTIPLE MYELOMA IN RELAPSE explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE MYELOMA IN RELAPSE trials appear
Sign up with your email to follow new studies for MULTIPLE MYELOMA IN RELAPSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo tackles tough myeloma in early trial
Disease control CompletedThis early-phase study tested a three-drug combination (ibrutinib, lenalidomide, and dexamethasone) in 14 people whose multiple myeloma had returned or stopped responding to treatment. The main goal was to find safe doses and identify side effects. While the approach aims to cont…
Matched conditions: MULTIPLE MYELOMA IN RELAPSE
Phase: PHASE1 • Sponsor: Alliance Foundation Trials, LLC. • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
Real-World study tracks myeloma Patients' adherence to carfilzomib combos
Knowledge-focused CompletedThis study looked at how consistently 359 adults with multiple myeloma (a blood cancer) took their prescribed carfilzomib combination treatments in everyday medical practice. Participants had already tried at least one prior therapy. The goal was to measure treatment adherence an…
Matched conditions: MULTIPLE MYELOMA IN RELAPSE
Sponsor: iOMEDICO AG • Aim: Knowledge-focused
Last updated May 26, 2026 10:30 UTC